Literature DB >> 21440448

Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.

Ban-Feng Ruan1, Xiang Lu, Jian-Feng Tang, Yao Wei, Xiao-Liang Wang, Yan-Bin Zhang, Li-Sheng Wang, Hai-Liang Zhu.   

Abstract

Twenty-three resveratrol derivatives possessing chalcone moiety were synthesized and characterized, and their biological activities were also evaluated as potential antiproliferation and tubulin polymerization inhibitors. Compound C19 exhibited the most potent activity in vitro, which inhibited the growth of HepG2, B16-F10, and A549 cell lines with IC(50) values of 0.2, 0.1, and 1.4 μg/mL, respectively. Compound C19 also exhibited significant tubulin polymerization inhibitory activity (IC(50)=2.6 μg/mL). Docking simulation was performed to position compound C19 into the tubulin-colchicine binding site to determine the probable binding mode.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21440448     DOI: 10.1016/j.bmc.2011.03.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  3,4',5-trans-Trimethoxystilbene; a natural analogue of resveratrol with enhanced anticancer potency.

Authors:  Fahad S Aldawsari; Carlos A Velázquez-Martínez
Journal:  Invest New Drugs       Date:  2015-02-28       Impact factor: 3.850

Review 2.  An overview of tubulin inhibitors that interact with the colchicine binding site.

Authors:  Yan Lu; Jianjun Chen; Min Xiao; Wei Li; Duane D Miller
Journal:  Pharm Res       Date:  2012-07-20       Impact factor: 4.200

Review 3.  Chalcone: A Privileged Structure in Medicinal Chemistry.

Authors:  Chunlin Zhuang; Wen Zhang; Chunquan Sheng; Wannian Zhang; Chengguo Xing; Zhenyuan Miao
Journal:  Chem Rev       Date:  2017-05-10       Impact factor: 60.622

Review 4.  Molecular targeted approaches to cancer therapy and prevention using chalcones.

Authors:  Danielle D Jandial; Christopher A Blair; Saiyang Zhang; Lauren S Krill; Yan-Bing Zhang; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

5.  Synthesis and evaluation of a series of resveratrol analogues as potent anti-cancer agents that target tubulin.

Authors:  Nikhil R Madadi; Hongliang Zong; Amit Ketkar; Chen Zheng; Narsimha R Penthala; Venumadhav Janganati; Shobanbabu Bommagani; Robert L Eoff; Monica L Guzman; Peter A Crooks
Journal:  Medchemcomm       Date:  2015-05-01       Impact factor: 3.597

6.  Novel hybrids derived from aspirin and chalcones potently suppress colorectal cancer in vitro and in vivo.

Authors:  Shan Lu; Obinna N Obianom; Yong Ai
Journal:  Medchemcomm       Date:  2018-08-27       Impact factor: 3.597

7.  (2E,4E)-1-(2-Hy-droxy-phen-yl)-5-phenyl-penta-2,4-dien-1-one.

Authors:  W A Silva; C C Gatto; G R Oliveira
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-08-02

8.  New Hybrids Based on Curcumin and Resveratrol: Synthesis, Cytotoxicity and Antiproliferative Activity against Colorectal Cancer Cells.

Authors:  Cristian Hernández; Gustavo Moreno; Angie Herrera-R; Wilson Cardona-G
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

9.  Diverse Molecular Targets for Chalcones with Varied Bioactivities.

Authors:  Bo Zhou; Chengguo Xing
Journal:  Med Chem (Los Angeles)       Date:  2015-08-22

Review 10.  Tubulin-interactive stilbene derivatives as anticancer agents.

Authors:  Renata Mikstacka; Tomasz Stefański; Jakub Różański
Journal:  Cell Mol Biol Lett       Date:  2013-07-01       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.